Literature DB >> 1318196

Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo.

H König1, H Ponta, H J Rahmsdorf, P Herrlich.   

Abstract

Phorbol esters stimulate and glucocorticoid hormones down-regulate a variety of promoters such as that of the collagenase gene through the transcription factor AP-1 (Fos/Jun). We now show by genomic footprinting of the collagenase promoter that phorbol ester treatment of cells results in the binding of AP-1 to its cognate DNA binding site in vivo. The DNA-protein contacts obtained in living cells are also found in vitro using cloned DNA and purified AP-1. Although in vitro synthesized glucocorticoid receptor can disturb the DNA binding of Jun homodimers, it does not interfere with the binding of Fos-Jun heterodimers or of purified AP-1 in vitro. Consistently, fully inhibitory doses of glucocorticoid hormone cause no change in apparent occupation of the AP-1 binding site in vivo. The hormone receptor acts without itself binding to DNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318196      PMCID: PMC556691          DOI: 10.1002/j.1460-2075.1992.tb05283.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  29 in total

1.  Transcription factor interactions: selectors of positive or negative regulation from a single DNA element.

Authors:  M I Diamond; J N Miner; S K Yoshinaga; K R Yamamoto
Journal:  Science       Date:  1990-09-14       Impact factor: 47.728

2.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity.

Authors:  W J Boyle; T Smeal; L H Defize; P Angel; J R Woodgett; M Karin; T Hunter
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

3.  A novel function of the transforming domain of E1a: repression of AP-1 activity.

Authors:  R Offringa; S Gebel; H van Dam; M Timmers; A Smits; R Zwart; B Stein; J L Bos; A van der Eb; P Herrlich
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

4.  The inner core of the serum response element mediates both the rapid induction and subsequent repression of c-fos transcription following serum stimulation.

Authors:  V M Rivera; M Sheng; M E Greenberg
Journal:  Genes Dev       Date:  1990-02       Impact factor: 11.361

5.  Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone.

Authors:  C Jonat; H J Rahmsdorf; K K Park; A C Cato; S Gebel; H Ponta; P Herrlich
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

6.  Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor.

Authors:  R Schüle; P Rangarajan; S Kliewer; L J Ransone; J Bolado; N Yang; I M Verma; R M Evans
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

7.  Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.

Authors:  H F Yang-Yen; J C Chambard; Y L Sun; T Smeal; T J Schmidt; J Drouin; M Karin
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

8.  Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun.

Authors:  M Touray; F Ryan; R Jaggi; F Martin
Journal:  Oncogene       Date:  1991-07       Impact factor: 9.867

9.  Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB.

Authors:  F C Lucibello; E P Slater; K U Jooss; M Beato; R Müller
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

10.  The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites.

Authors:  A Gutman; B Wasylyk
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

View more
  62 in total

Review 1.  Molecular mechanisms of glucocorticoid action: what is important?

Authors:  R Newton
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

2.  A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kappaB-regulated promoters.

Authors:  Olivier Kassel; Sandra Schneider; Christine Heilbock; Margarethe Litfin; Martin Göttlicher; Peter Herrlich
Journal:  Genes Dev       Date:  2004-10-15       Impact factor: 11.361

3.  Glucocorticoid and growth factor synergism requirement for Notch4 chromatin domain activation.

Authors:  Jing Wu; Emery H Bresnick
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

4.  Antagonism between Nur77 and glucocorticoid receptor for control of transcription.

Authors:  A Philips; M Maira; A Mullick; M Chamberland; S Lesage; P Hugo; J Drouin
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

5.  Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes.

Authors:  Nagesha A S Rao; Melysia T McCalman; Panagiotis Moulos; Kees-Jan Francoijs; Aristotelis Chatziioannou; Fragiskos N Kolisis; Michael N Alexis; Dimitra J Mitsiou; Hendrik G Stunnenberg
Journal:  Genome Res       Date:  2011-07-12       Impact factor: 9.043

6.  Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells.

Authors:  Margherita Gallicchio; Arianna Carolina Rosa; Elisa Benetti; Massimo Collino; Chiara Dianzani; Roberto Fantozzi
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

7.  Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.

Authors:  H Schäcke; T M Zollner; W D Döcke; H Rehwinkel; S Jaroch; W Skuballa; R Neuhaus; E May; U Zügel; K Asadullah
Journal:  Br J Pharmacol       Date:  2009-05-06       Impact factor: 8.739

8.  Inhibition of gelatinase activity in human airway epithelial cells and fibroblasts by dexamethasone and beclomethasone.

Authors:  J E Carver; W A Galloway; C Robinson
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

9.  Regulation of proto-oncogene expression in adult and developing lungs.

Authors:  R Molinar-Rode; R J Smeyne; T Curran; J I Morgan
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro.

Authors:  T K Kerppola; D Luk; T Curran
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.